Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

OVERVIEW

  • = immune complex mediated hypersensitivity -> severe erythema multiforme.
  • separation of the epidermis from the dermis
  • most authors believe toxic epidermal necrolysis (TEN) and SJS are different ends of the same spectrum of disease
  • erythema multiforme major is considered a distinct disorder
  • serious systemic disorder (multisystem)
  • mortality proportional to BSA

Disease nomenclature is based on the extent of the skin lesions

  • < 10% BSA = SJS
  • 10-30% BSA = SJS/ TEN overlap syndrome
  • > 30%= TEN

CAUSES (MIDI)

  • malignancy related (carcinomas and lymphomas)
  • infectious (viral, bacterial, fungal, protozoal)
  • drug induced (penicillins, sulfa drugs, quinolones, cephalosporins, anticonvulsants, COX-2, immunosuppressants, allopurinol, corticosteroids)
  • idiopathic

HISTORY

  • prodrome: systemic symptoms (1-14 days)
  • co-morbidities: HIV and SLE
  • painful and burning rash with mucosal involvement

EXAMINATION

  • mucocutaneous lesions: papules/vesicles -> clusters, nonpruritic involving all mucous membranes (oropharynx, airway, urethra, cornea) -> rupture leaving denuded skin
  • can be target lesions
  • %BSA involved
  • fluid status
  • nutritional status

INVESTIGATIONS

  • standard investigations involved in resuscitation
  • skin biopsy: subepidermal bullae, epidermal necrosis, perivascular lymphocytic infiltration
  • skin and blood cultures
  • bronchoscopy – airway involvement
  • endoscopy – GI involvement

MANAGEMENT

  • determined by the severity of the syndrome

Resuscitate

  • A – may need to be intubated c/o mucosal involvement
  • B – protective lung ventilation (can develop pulmonary complications: secretions, sloughing of bronchial epithelim, BOOP)
  • C – fluid resuscitation similar to burn patient, large volumes proportional to BSA involved, will have a hyperdynamic circulation with vasodilatory shock (managed with careful fluids and inotropic support), monitor end-organ function -> urine output >1mL/kg/hr
  • D – multimodal analgesia required -> may have to intubated and ventilated for analgesia
  • E – keep warm and isolated if possible to decrease risk of superinfection, humified environment, warm OT

Specific treatment

  • stop offending agent
  • identify and treat underlying disease and secondary infection (antibiotics)
  • burns dressings
  • antibiotics for documented invasive superinfection
  • avoid antibiotics that may exacerbate conditions (silver sulphadizine -> sulpha based)
  • IgG and steroids – controversial (EuroSCAR study)
  • consider plasma exchange

General treatment

  • careful management of fluid-balance and electrolyte abnormalities required
  • nutrition
  • thromboprophylaxis

Disposition

  • management in a burns unit if large TBSA involvement
  • keep family informed
  • consult dermatology and plastic surgery early and involve burns nurse


CCC 700 6

Critical Care

Compendium

Chris is an Intensivist and ECMO specialist at The Alfred ICU, where he is Deputy Director (Education). He is a Clinical Adjunct Associate Professor at Monash University, the Lead for the  Clinician Educator Incubator programme, and a CICM First Part Examiner.

He is an internationally recognised Clinician Educator with a passion for helping clinicians learn and for improving the clinical performance of individuals and collectives. He was one of the founders of the FOAM movement (Free Open-Access Medical education) has been recognised for his contributions to education with awards from ANZICS, ANZAHPE, and ACEM.

His one great achievement is being the father of three amazing children.

On Bluesky, he is @precordialthump.bsky.social and on the site that Elon has screwed up, he is @precordialthump.

| INTENSIVE | RAGE | Resuscitology | SMACC

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.